Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Fennec Pharmaceuticals Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +13 vs. Q3 2022
- Shares held
- 12.5M
- +1.12M (+9.9%) vs. Q3 2022
- Total value
- $119.5M
- +$27.7M (+30.2%) vs. Q3 2022
- New holders
- 18
- 10 more added
- Sold out
- 5
- 7 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $175.1M |
| Q1 2026 | 90 | $99.6M |
| Q4 2025 | 96 | $119.6M |
| Q3 2025 | 84 | $129.8M |
| Q2 2025 | 78 | $112.9M |
| Q1 2025 | 68 | $81.6M |
| Q4 2024 | 64 | $101.4M |
| Q3 2024 | 63 | $74.6M |
| Q2 2024 | 64 | $87.7M |
| Q1 2024 | 65 | $161.1M |
| Q4 2023 | 56 | $168.4M |
| Q3 2023 | 55 | $107.6M |
| Q2 2023 | 56 | $124.5M |
| Q1 2023 | 54 | $108.5M |
| Q4 2022 | 43 | $119.5M |
| Q3 2022 | 31 | $92.1M |
| Q2 2022 | 28 | $63.2M |
| Q1 2022 | 28 | $64.1M |
| Q4 2021 | 30 | $49.9M |
| Q3 2021 | 32 | $109.7M |
| Q2 2021 | 39 | $88.0M |
| Q1 2021 | 53 | $89.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 64 | $614 | 0.00% | −3,035−97.9% | Reduced |
| JPMorgan Chase & Co | 70 | $1.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 112 | $1.07K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 170 | $1.63K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 291 | $3.00K | 0.00% | +277+1,978.6% | Added |
| Bank of America Corp | 2,200 | $21.1K | 0.00% | −420−16.0% | Reduced |
| Simplex Trading, LLC | 2,921 | $28.0K | 0.00% | +2,921 | New |
| Tower Research Capital LLC (TRC) | 3,092 | $29.0K | 0.00% | −519−14.4% | Reduced |
| Advisor Group Holdings, Inc. | 3,892 | $37.0K | 0.00% | −7,218−65.0% | Reduced |
| Barclays PLC | 9,260 | $88.9K | 0.00% | +9,260 | New |
| NewEdge Wealth, LLC | 10,000 | $96.0K | 0.00% | +10,000 | New |
| Ancora Advisors, LLC | 12,245 | $118.0K | 0.00% | +5,000+69.0% | Added |
| Man Group plc | 13,630 | $130.8K | 0.00% | +13,630 | New |
| Citigroup Inc | 16,848 | $162.8K | 0.00% | +16,848 | New |
| Qube Research & Technologies Ltd | 17,272 | $165.8K | 0.00% | +17,272 | New |
| Geode Capital Management, LLC | 19,507 | $187.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 20,985 | $201.5K | 0.00% | +20,985 | New |
| Jump Financial, LLC | 20,991 | $201.5K | 0.01% | +20,991 | New |
| Jane Street Group, LLC | 25,866 | $248.3K | 0.00% | +11,359+78.3% | Added |
| Citadel Advisors LLC | 28,054 | $269.3K | 0.00% | +12,378+79.0% | Added |
| Bridgeway Capital Management, LLC | 34,200 | $328.3K | 0.01% | +34,200 | New |
| Hartford Financial Management Inc. | 39,848 | $382.5K | 0.10% | 00.0% | Unchanged |
| Morgan Stanley | 45,376 | $435.6K | 0.00% | +9,314+25.8% | Added |
| BlackRock Inc. | 50,544 | $485.2K | 0.00% | +1,177+2.4% | Added |
| Tamar Securities, LLC | 53,475 | $513.4K | 0.16% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 55,000 | $528.0K | 0.00% | +55,000 | New |
| Apis Capital Advisors, LLC | 58,000 | $556.8K | 0.65% | +58,000 | New |
| Two Sigma Investments, LP | 87,671 | $841.6K | 0.00% | +87,671 | New |
| 1492 Capital Management LLC | 94,870 | $910.8K | 0.59% | +94,870 | New |
| CIBC World Markets Inc. | 99,363 | $954.0K | 0.00% | +99,363 | New |
| Susquehanna International Group, LLP | 107,613 | $1.03M | 0.00% | +107,613 | New |
| Millennium Management LLC | 127,289 | $1.22M | 0.00% | −122,048−48.9% | Reduced |
| Gendell Jeffrey L | 153,070 | $1.47M | 0.13% | +153,070 | New |
| EAM Investors, LLC | 176,452 | $1.69M | 0.35% | −368−0.2% | Reduced |
| Tamarack Advisers, LP | 213,000 | $2.04M | 1.48% | +38,000+21.7% | Added |
| Opaleye Management Inc. | 272,200 | $2.61M | 0.91% | +272,200 | New |
| 683 Capital Management, LLC | 300,000 | $2.88M | 0.26% | −84,824−22.0% | Reduced |
| Harbert Fund Advisors, Inc. | 316,949 | $3.04M | 2.62% | +127,199+67.0% | Added |
| DG Capital Management, LLC | 1,021,952 | $9.81M | 6.00% | +16,851+1.7% | Added |
| Avoro Capital Advisors LLC | 1,200,000 | $11.5M | 0.17% | 00.0% | Unchanged |
| Solas Capital Management, LLC | 1,252,388 | $12.0M | 7.21% | +121,221+10.7% | Added |
| Sonic GP LLC | 2,407,357 | $23.1M | 17.34% | +2,407,357 | New |
| Southpoint Capital Advisors LP | 4,077,214 | $39.1M | 1.01% | 00.0% | Unchanged |
| Sonic Fund II, L.P. | 0 | $0 | 0.00% | −2,407,357−100.0% | Sold out |
| Valley Forge Investment Consultants Inc Adv | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −14,924−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |